RANKL-independent osteoclastogenesis in Paget's disease

RANKL-independent osteoclastogenesis in Paget's disease

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	Jones, F, Knowles, H, Wass, J, Athanasou, N
التنسيق:	Journal article
منشور في:	2008

مواد مشابهة

Osteoclast differentiation in Paget's disease is hypersensitive to RANKL.
حسب: Neale, S, وآخرون
منشور في: (2000)

Ewing sarcoma cells express RANKL and support osteoclastogenesis
حسب: Taylor, R, وآخرون
منشور في: (2011)

Ewing sarcoma cells express RANKL and support osteoclastogenesis.
حسب: Taylor, R, وآخرون
منشور في: (2011)

Osteoclast differentiation from circulating mononuclear precursors in Paget's disease is hypersensitive to 1,25-dihydroxyvitamin D(3) and RANKL.
حسب: Neale, S, وآخرون
منشور في: (2000)

Bone stromal cells in pagetic bone and Paget's sarcoma express RANKL and support human osteoclast formation.
حسب: Sun, S, وآخرون
منشور في: (2006)

RANKL-independent osteoclastogenesis in the SH3BP2 cherubism mice
حسب: Mizuho Kittaka, وآخرون
منشور في: (2020-06-01)

Puerarin inhibits the osteoclastogenesis by inhibiting RANKL-dependent and –independent autophagic responses
حسب: Guoyou Zhang, وآخرون
منشور في: (2019-10-01)

RANKL-independent human osteoclast formation with APRIL, BAFF, NGF, IGF I and IGF II.
حسب: Hemingway, F, وآخرون
منشور في: (2011)

RANKL-independent human osteoclast formation with APRIL, BAFF, NGF, IGF I and IGF II.
حسب: Hemingway, F, وآخرون
منشور في: (2011)

Lipopolysaccharide- TLR-4 Axis regulates Osteoclastogenesis independent of RANKL/RANK signaling
حسب: Mohammed S. AlQranei, وآخرون
منشور في: (2021-03-01)

RANKL-Expressing Ectopic Extramammary Paget’s Disease on the Lower Abdomen
حسب: Akiko Hagiwara-Takita, وآخرون
منشور في: (2016-06-01)

RANKL signaling and osteoclastogenesis is negatively regulated by cardamonin.
حسب: Bokyung Sung, وآخرون
منشور في: (2013-01-01)

Investigation of osteoclastogenic signalling of the RANKL substitute LIGHT
حسب: Hemingway, F, وآخرون
منشور في: (2013)

Investigation of osteoclastogenic signalling of the RANKL substitute LIGHT.
حسب: Hemingway, F, وآخرون
منشور في: (2013)

RANKL-dependent and RANKL-independent mechanisms of macrophage-osteoclast differentiation in breast cancer.
حسب: Lau, Y, وآخرون
منشور في: (2007)

Tetrandrine inhibits RANKL-induced osteoclastogenesis by promoting the degradation of TRAIL
حسب: Jiarui Li, وآخرون
منشور في: (2022-11-01)

Inhibitory activity on RANKL-mediated osteoclastogenesis of Glossogyne tenuifolia extract
حسب: Shih-Wei Wang, وآخرون
منشور في: (2014-01-01)

Parkin Inhibits RANKL-Induced Osteoclastogenesis and Ovariectomy-Induced Bone Loss
حسب: Weiduo Hou, وآخرون
منشور في: (2022-10-01)

Niclosamide and its derivative DK‐520 inhibit RANKL‐induced osteoclastogenesis
حسب: Yurui Jiao, وآخرون
منشور في: (2020-08-01)

Infection of RANKL-primed RAW-D macrophages with Porphyromonas gingivalis promotes osteoclastogenesis in a TNF-α-independent manner.
حسب: Akiko Kukita, وآخرون
منشور في: (2012-01-01)

Involvement of RANKL-dependent/independent mechanisms in osteoclast formation in aseptic loosening
حسب: Sabokbar, A, وآخرون
منشور في: (2001)

Angiopoietin-like 4 promotes osteosarcoma cell proliferation and migration and stimulates osteoclastogenesis
حسب: Zhang, T, وآخرون
منشور في: (2018)

The Notch1 signaling pathway directly modulates the human RANKL-induced osteoclastogenesis
حسب: Costanzo Padovano, وآخرون
منشور في: (2023-12-01)

The Effect of Alendronate on Osteoclastogenesis in Different Combinations of M-CSF and RANKL Growth Factors
حسب: Věra Hedvičáková, وآخرون
منشور في: (2021-03-01)

Specnuezhenide suppresses diabetes-induced bone loss by inhibiting RANKL-induced osteoclastogenesis
حسب: Ye Xiaoshuang, وآخرون
منشور في: (2022-08-01)

Pristimerin Suppresses RANKL-Induced Osteoclastogenesis and Ameliorates Ovariectomy-Induced Bone Loss
حسب: Dahu Qi, وآخرون
منشور في: (2021-01-01)

Inhibitory Effect of Chlorpromazine on RANKL-Induced Osteoclastogenesis in Mouse Bone Marrow Cells
حسب: Hiroharu Kawamura, وآخرون
منشور في: (2011-01-01)

BCI Suppresses RANKL-Mediated Osteoclastogenesis and Alleviates Ovariectomy-Induced Bone Loss
حسب: Chenhui Cai, وآخرون
منشور في: (2021-11-01)

Tetrandrine Prevents Bone Loss in Ovariectomized Mice by Inhibiting RANKL-Induced Osteoclastogenesis
حسب: Zeyuan Zhong, وآخرون
منشور في: (2020-01-01)

Direct identification of osteoblast progenitor cells in Paget's disease
حسب: Joyner, C, وآخرون
منشور في: (1999)

Rankl-independent induction of human osteoclast formation and bone resorption by TGF-beta
حسب: Itonaga, I, وآخرون
منشور في: (2002)

Giant-cell-rich pseudotumour in Paget's disease.
حسب: Gamage, N, وآخرون
منشور في: (2013)

Chemotherapy-induced adipocyte senescence triggers bone loss through RANKL-mediated osteoclastogenesis
حسب: Ganesh Kumar Raut, وآخرون
منشور في: (2024-04-01)

α-Linolenic Acid Inhibits RANKL-Induced Osteoclastogenesis In Vitro and Prevents Inflammation In Vivo
حسب: Yufeng Deng, وآخرون
منشور في: (2023-02-01)

Nardosinone Suppresses RANKL-Induced Osteoclastogenesis and Attenuates Lipopolysaccharide-Induced Alveolar Bone Resorption
حسب: Chenguang Niu, وآخرون
منشور في: (2017-09-01)

Carbon Monoxide Inhibits Receptor Activator of NF-κB (RANKL)-Induced Osteoclastogenesis
حسب: Feng-Jen Tseng, وآخرون
منشور في: (2015-07-01)

PRMT1 mediates RANKL-induced osteoclastogenesis and contributes to bone loss in ovariectomized mice
حسب: Joo-Hee Choi, وآخرون
منشور في: (2018-08-01)

Vindoline Inhibits RANKL-Induced Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss in Mice
حسب: Yunfei Zhan, وآخرون
منشور في: (2020-01-01)

Oligomeric proanthocyanidins ameliorates osteoclastogenesis through reducing OPG/RANKL ratio in chicken's embryos
حسب: Gengsheng Yu, وآخرون
منشور في: (2024-06-01)

Osteoclast-derived IGF1 induces RANKL production in osteocytes and contributes to pagetic lesion formation
حسب: Kazuaki Miyagawa, وآخرون
منشور في: (2023-07-01)